Chimeric Therapeutics Limited
A$0.2
4
+A$0+0% Monday 03:55
Statistics
Day High
0
Day Low
0
52W High
0.01
52W Low
0
Volume
1,502,000
Avg. Volume
-
Mkt Cap
821.76M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
27FebExpected
Expected EPS
N/A
Actual EPS
N/A
Financials
-262.79%Profit Margin
Unprofitable7.94MRevenue
-20.86MNet Income
People Also Follow
This list is based on the watchlists of people on Stock Events who follow CHM.AU. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
CRISPR Therapeutics
CRSP
Mkt Cap5.57B
Allogene Therapeutics
ALLO
Mkt Cap791.75M
Precigen
PGEN
Mkt Cap1.41B
Gilead Sciences
GILD
Mkt Cap170.84B
Novartis
NVS
Mkt Cap293.34B
Sangamo Therapeutics
SGMO
Mkt Cap108.54M
About
Chimeric Therapeutics Limited, a clinical stage cell therapy company, develops and commercializes a range of cell therapies for oncology in Australia. The company develops CHM CDH17-directed CAR T cell therapy for the treatment of advanced colorectal cancer, gastric cancer, and intestinal neuroendocrine tumors; and CHM CLTX, a chlorotoxin-directed CAR T cell therapy to treat patients with recurrent or progressive glioblastoma and membrane-bound matrix metalloproteinase-2 (MMP2) expressing solid tumors. It also develops CHM CORE-NK for the treatment of acute myeloid leukaemia/colorectal cancer, acute myeloid cancer, blood cancer, solid tumors, MMP2 expressing solid tumors, and CDH17 expressing solid tumors. The company was incorporated in 2020 and is based in Carlton, Australia.
Show more...
CEO
Dr. Rebecca McQualter
Country
Australia
ISIN
AU0000121576
Listings
0 Comments
Share your thoughts
FAQ
What is Chimeric Therapeutics Limited stock price today?▼
The current price of CHM.AU is A$0.2 AUD — it has increased by +0% in the past 24 hours. Watch Chimeric Therapeutics Limited stock price performance more closely on the chart.
What is Chimeric Therapeutics Limited stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Chimeric Therapeutics Limited stocks are traded under the ticker CHM.AU.
Is Chimeric Therapeutics Limited stock price growing?▼
CHM.AU stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Chimeric Therapeutics Limited has showed a -60% decrease.
What is Chimeric Therapeutics Limited market cap?▼
Today Chimeric Therapeutics Limited has the market capitalization of 821.76M
When is the next Chimeric Therapeutics Limited earnings date?▼
Chimeric Therapeutics Limited is going to release the next earnings report on August 28, 2026.
What is Chimeric Therapeutics Limited revenue for the last year?▼
Chimeric Therapeutics Limited revenue for the last year amounts to 7.94M AUD.
What is Chimeric Therapeutics Limited net income for the last year?▼
CHM.AU net income for the last year is -20.86M AUD.
In which sector is Chimeric Therapeutics Limited located?▼
Chimeric Therapeutics Limited operates in the Health & Wellness sector.
When did Chimeric Therapeutics Limited complete a stock split?▼
The last stock split for Chimeric Therapeutics Limited was on April 22, 2026 with a ratio of 1:100.
Where is Chimeric Therapeutics Limited headquartered?▼
Chimeric Therapeutics Limited is headquartered in Carlton, Australia.